These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza. Ison MG; Gnann JW; Nagy-Agren S; Treannor J; Paya C; Steigbigel R; Elliott M; Weiss HL; Hayden FG; Antivir Ther; 2003 Jun; 8(3):183-90. PubMed ID: 12924534 [TBL] [Abstract][Full Text] [Related]
24. Antivirals for influenza: what is their role in the older patient? Dumyati G; Falsey AR Drugs Aging; 2002; 19(10):777-86. PubMed ID: 12390054 [TBL] [Abstract][Full Text] [Related]
25. Summaries for patients. Cost-effective management of flu in adults older than 65 years of age. Ann Intern Med; 2003 Sep; 139(5 Pt 1):I27. PubMed ID: 12965955 [No Abstract] [Full Text] [Related]
26. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group. Lancet; 1998 Dec; 352(9144):1877-81. PubMed ID: 9863784 [TBL] [Abstract][Full Text] [Related]
27. [Neuraminidase inhibitor permitted. The first pill against influenza]. MMW Fortschr Med; 2002 Oct; 144(41):56. PubMed ID: 12474367 [No Abstract] [Full Text] [Related]
28. Neuraminidase inhibitors for treatment of influenza A and B infections. MMWR Recomm Rep; 1999 Dec; 48(RR-14):1-9. PubMed ID: 10632443 [TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of newer treatment strategies for influenza. Smith KJ; Roberts MS Am J Med; 2002 Sep; 113(4):300-7. PubMed ID: 12361816 [TBL] [Abstract][Full Text] [Related]